Submissions for variant NM_032043.2(BRIP1):c.1474-3T>C (rs552752779)

Total submissions: 9

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Ambry Genetics	RCV000164980	SCV000215673	uncertain significance	Hereditary cancer-predisposing syndrome	2018-01-09	criteria provided, single submitter	clinical testing	Lines of evidence used in support of classification: Insufficient or conflicting evidence,In silico models in agreement (benign)
Color	RCV000164980	SCV000902752	benign	Hereditary cancer-predisposing syndrome	2016-11-17	criteria provided, single submitter	clinical testing
Counsyl	RCV000662494	SCV000785013	uncertain significance	Fanconi anemia, complementation group J; Neoplasm of ovary	2017-03-14	criteria provided, single submitter	clinical testing
GeneDx	RCV000430204	SCV000512417	benign	not specified	2015-09-21	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genetic Services Laboratory, University of Chicago	RCV000430204	SCV000593766	uncertain significance	not specified	2016-12-27	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000348888	SCV000404610	uncertain significance	Fanconi anemia	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000387131	SCV000404611	uncertain significance	Neoplasm of the breast	2016-06-14	criteria provided, single submitter	clinical testing
Integrated Genetics/Laboratory Corporation of America	RCV000589721	SCV000699667	benign	not provided	2017-05-08	criteria provided, single submitter	clinical testing	Variant summary: The BRIP1 c.1474-3T>C variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing, though ESE finder predicts the variant may introduce an SF2/ASF ESE site at the locus. However, these predictions have yet to be confirmed by functional studies. This variant was found in the large control database ExAC in 33 of 120864 control chromosomes from all ethnicities, but was predominantly observed in the South Asian subpopulation at a frequency of 0.001879 (31/16496). This frequency is about 30 times the estimated maximal expected allele frequency of a pathogenic BRIP1 variant (0.0000625), strongly suggesting this is likely a benign polymorphism found primarily in the populations of South Asian origin. Multiple clinical diagnostic laboratories have conflicting classifications for this variant including uncertain significance (4x in ClinVar) and benign (1x in ClinVar). The variant of interest has not, to our knowledge, been reported in affected individuals via publications, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.
Invitae	RCV000199588	SCV000255149	uncertain significance	Familial cancer of breast; Fanconi anemia, complementation group J	2017-07-19	criteria provided, single submitter	clinical testing